Kristin Anne Torres Mowat

Backing Healthcare & Healthtech Innovators | Ex-Castlight & DaVita

📍 United States🔄 Updated August 2026💼 1 investments📅 8 years investing🗓 Last invested Jan 2018
VC🌍 United States
1
Total investments
0
Early stage
0
Mid stage
0
Late stage
8y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor | Advisor
2018
Management Consultants
Experience · 7 entries
All (7)
Investments (1)
2021
Partner + Strategic Networks
Jul 2021
Health Velocity Capital invests in growth-stage healthcare software and services companies. Spanning three decades as investors, entrepreneurs, and operators, our principals have invested in and helped build some of healthcares most impactful innovators -- companies that became industry leaders and that created entirely new markets, a few of which include Teladoc Health (NYSE: TDOC), Tivity Health (NASDAQ: TVTY), Change Healthcare (NASDAQ: CHNG), Aspire Healthcare, and Livongo (NASDAQ: LVGO). In addition to investing on behalf of institutional investors, we are proud to invest on behalf of a number of our nation’s largest and most influential healthcare organizations and a number of current and former healthcare senior executives and leaders. Collectively, our investors represent organizations that provide health insurance to more than 140 million Americans, operate more than 500 hospitals, provide pharmacy and PBM services to almost every American, and provide software and services to every major hospital in the United States. For more information, please visit www.healthvelocitycapital.com.
2018
Investor | Advisor
2018
Management Consultants
2005
Summer Associate
2005
Pillsbury is one of the world’s foremost law firms, operating at the intersection of technology innovation, capital and government. From microchips to blue chips, Pillsbury represents clients ranging from entrepreneurs working out of a garage to the largest public and private companies. The firm is known for market-leading transactional, disputes and regulatory practices, with teams of lawyers and business professionals collaborating across disciplines and delivering exemplary client service. Advising clients across the Americas, Europe, Asia, Africa and the Middle East, Pillsbury is consistently recognized for excellence by Chambers & Partners, The Legal 500, Financial Times and other publications. Attorney Advertising. Results depend on a number of factors unique to each matter. Prior results do not guarantee a similar outcome.
2004
Summer Associate, Business Development
Jun 2004
Welcome to the official LinkedIn page for McKesson Corporation. Were an impact-driven healthcare organization dedicated to “Advancing Health Outcomes For All.” As a global healthcare company, we touch virtually every aspect of health. Our leaders empower our people to lead with a growth mindset and deliver excellence for our customers, partners, and the wellbeing of people, everywhere. We work with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services that make quality care more accessible and affordable. Delivering better health outcomes for our employees, our communities, and our environment. Every day, we strive to inspire and enable people to reach their full potential. To learn more about how #TeamMckesson helps improve care in every setting, visit: https://bit.ly/3xadvB0
2003
Summer Senior Associate
2003
Chiron Corporation was an American multinational biotechnology firm based in Emeryville, California that was acquired by Novartis International AG on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chirons business and research was in three main areas: biopharmaceuticals, vaccines and blood testing. Chirons vaccines and blood testing units were been combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals were integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit ("Novartis Diagnostics"​) to Grifols, S.A. (Barcelona, Spain) and announced agreements for the sale of its vaccines unit ("Novartis Vaccines"​).
Show all 7 entries ↓